If the customer can choose, will he still choose a Philips? This question is urgent now that problems with breathing and apnea equipment continue to plague the group. According to an image expert, Philips can limit the damage by playing an open card.
That just won’t work on the stock market. As the US regulator demands clarification about the silicone layer in the new sleep apnea devicesOn Monday, that was enough to make the Philips share price collapse like a plum pudding.
The share plunged more than ten percent to more than 37 euros. And that’s not exactly an incidental blow. Before the announcement of the recall in April, the Philips share was still above 50 euros. Philips has surrendered a quarter of its market value in just seven months. And that while the AEX index has risen to a record high and has gained 17 percent since that period.
–
